Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Apr;99(15):e19817.
doi: 10.1097/MD.0000000000019817.

Transesophageal and intracardiac ultrasound in arrhythmogenic right ventricular dysplasia/cardiomyopathy: Two case reports

Affiliations
Case Reports

Transesophageal and intracardiac ultrasound in arrhythmogenic right ventricular dysplasia/cardiomyopathy: Two case reports

Gabriel Cismaru et al. Medicine (Baltimore). 2020 Apr.

Abstract

Rationale: Two-dimensional echocardiography (2D echo) is a major tool for the diagnosis of Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C). However 2D echo can skip regional localized anomalies of the right ventricular wall. We aimed to determine whether transesophageal and intracardiac ultrasound can provide additional information, on the right ventricular abnormalities compared to 2D echo.

Patient concerns: Case 1 is a 30-year-old patient that presented in the Emergency Department with multiple episodes of fast monomorphic ventricular tachycardia (VT) manifested by palpitations and diziness. Case 2 is a 65-year-old patient that also presented with episodes of ventircular tachycardia associated with low blood pressure.

Diagnosis: Both patients had a clear diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy confirmed by cardiac magnetic resonance imaging.

Intervention: In both patients transesophageal and intracardiac ultrasound was performed, which brought more information on the diagnosis of ARVD/C compared to transthoracic echocardiograpy.

Outcomes: The first patient was implanted with an internal cardiac defibrillator and treated with Sotalol for VT recurrences. He presented episodes of VT during follow-up, treated with antitachycardia pacing. The second patient was implanted with an internal cardiac defibrillator and treated with Sotalol without any VT recurrence at 18 month-follow-up.

Lessons: Transesophageal echocardiography and intracardiac echocardiography can provide additional information on small, focal structural abnormalities in patients with ARVD/C: bulges, saculations, aneurysms with or without associated thrombus, partial or complete loss of trabeculations and hypertrophy of the moderator band. These changes are particularly important in cases with "concealed" form of the disease in which no morphological abnormalities are evident in transthoracic echocardiograpy.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to disclose.

Figures

Figure 1
Figure 1
Transesophageal echography using a multiplanar probe. (A) Midesophageal view 4°: in the upper part of the image the left atrium can be seen- this is the closest anatomical structure to the esophagus. Separated by the interatrial septum, in the inferior part of the image lies the right atrium. The interatrial septum is convex towards the left atrium as the pressure inside the right atrium is high, given by the dilation of the right ventricle, tricuspid ring with subsequent tricuspid regurgitation. (B) Artwork with the structures seen in TEE. (C) Midesophageal view 36°: at the level of the right ventricle the moderator band (MB) can be visualized passing the ventricular cavity from the interventricular septum to the lateral wall where the anterior papillary muscle can be found. (D) Artwork with the moderator band as seen in TEE. TEE = transesophageal echocardiography.
Figure 2
Figure 2
Intracardiac echography using a rotational probe. (A) The ViewFlex probe is inserted near the apex of the right ventricle. Please note the normal trabeculations which are present at the level of the lateral wall (yellow arrow). (B) The ViewFlex probe is inserted between the tricuspid valve and the apex of right ventricle. Please note the absence of normal trabeculations at the level of the lateral wall (yellow arrow). The regional absence of the trabeculations at the level of the “triangle of dysplasia” could not be seen with 2D echo and transesophageal echocardiography. 2D = 2-dimensional.
Figure 3
Figure 3
Intracardiac echocardiography using a sectorial probe. (A) Chest X-ray: the ICE probe is inserted in the middle of the right atrium. (B) The RA (44 mm), RV (52 mm), and RVOT (48 mm) are dilated. (C) As the tricuspid ring is dilated, a moderate tricuspid regurgitation is present. (D) Chest X-ray: Intracardiac echography with the probe inserted inside the right ventricle. (E) Near the apex of the right ventricle the moderator band can be visualized (yellow arrow). (F) Chest X-ray: Intracardiac echography with the probe inserted inside the right ventricle. (G) The patient is implanted with an ICD (red arrow) for the secondary prevention of sudden cardiac death as he presented many episodes of ventricular tachycardia. At the apex of the right ventricle a localized aneurysm can be seen with a pediculated thrombus (yellow arrow). ICD = internal cardiac defibrillator, ICE = intracardiac echocardiography, RV = right ventricle, RVOT = right ventricular outflow tract.

References

    1. McKenna WJ, Thiene G, Nava A, et al. Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology. Br Heart J 1994;71:215–8. - PMC - PubMed
    1. Marcus FI, McKenna WJ, Sherrill D, et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria. Eur Heart J 2010;31:806–14. - PMC - PubMed
    1. Marcus FI, Fontaine GH, Guiraudon G, et al. Right ventricular dysplasia: a report of 24 adult cases. Circulation 1982;65:384–98. - PubMed
    1. Richardson P, McKenna W, Bristow M, et al. Report of the 1995 World Health Organisation/International Society and Federation of Cardiology task force on the definition and classification of cardiomyopathies. Circulation 1996;93:841–2. - PubMed
    1. Daubert JC, Descaves C, Foulgoc JL, et al. Critical analysis of cineangiographic criteria for diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Arch Mal Coeur 1991;84:33–8. - PubMed

MeSH terms

Substances